322 related articles for article (PubMed ID: 29499483)
21. An
Asciolla JJ; Miele MM; Hendrickson RC; Resh MD
J Biol Chem; 2017 Aug; 292(33):13507-13513. PubMed ID: 28655768
[TBL] [Abstract][Full Text] [Related]
22. 1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.
Miller-Moslin K; Peukert S; Jain RK; McEwan MA; Karki R; Llamas L; Yusuff N; He F; Li Y; Sun Y; Dai M; Perez L; Michael W; Sheng T; Lei H; Zhang R; Williams J; Bourret A; Ramamurthy A; Yuan J; Guo R; Matsumoto M; Vattay A; Maniara W; Amaral A; Dorsch M; Kelleher JF
J Med Chem; 2009 Jul; 52(13):3954-68. PubMed ID: 19469545
[TBL] [Abstract][Full Text] [Related]
23. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
Takebe N; Miele L; Harris PJ; Jeong W; Bando H; Kahn M; Yang SX; Ivy SP
Nat Rev Clin Oncol; 2015 Aug; 12(8):445-64. PubMed ID: 25850553
[TBL] [Abstract][Full Text] [Related]
24. Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer.
Yun JI; Kim HR; Park H; Kim SK; Lee J
Arch Pharm Res; 2012 Aug; 35(8):1317-33. PubMed ID: 22941475
[TBL] [Abstract][Full Text] [Related]
25. Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth.
Wang J; Peng Y; Liu Y; Yang J; Ding N; Tan W
BMC Cancer; 2015 Aug; 15():595. PubMed ID: 26296751
[TBL] [Abstract][Full Text] [Related]
26. Chemical Modulation of WNT Signaling in Cancer.
Zhang LS; Lum L
Prog Mol Biol Transl Sci; 2018 Jan; 153():245-269. PubMed ID: 29389519
[TBL] [Abstract][Full Text] [Related]
27. Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
Liu J; Pan S; Hsieh MH; Ng N; Sun F; Wang T; Kasibhatla S; Schuller AG; Li AG; Cheng D; Li J; Tompkins C; Pferdekamper A; Steffy A; Cheng J; Kowal C; Phung V; Guo G; Wang Y; Graham MP; Flynn S; Brenner JC; Li C; Villarroel MC; Schultz PG; Wu X; McNamara P; Sellers WR; Petruzzelli L; Boral AL; Seidel HM; McLaughlin ME; Che J; Carey TE; Vanasse G; Harris JL
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20224-9. PubMed ID: 24277854
[TBL] [Abstract][Full Text] [Related]
28. Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways.
Liang G; Liu M; Wang Q; Shen Y; Mei H; Li D; Liu W
Oncotarget; 2017 Apr; 8(17):28510-28525. PubMed ID: 28212537
[TBL] [Abstract][Full Text] [Related]
29. Combined inhibition of morphogen pathways demonstrates additive antifibrotic effects and improved tolerability.
Distler A; Lang V; Del Vecchio T; Huang J; Zhang Y; Beyer C; Lin NY; Palumbo-Zerr K; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1264-8. PubMed ID: 24445254
[TBL] [Abstract][Full Text] [Related]
30. Novel Small Molecule Inhibitors of Cancer Stem Cell Signaling Pathways.
Abetov D; Mustapova Z; Saliev T; Bulanin D; Batyrbekov K; Gilman CP
Stem Cell Rev Rep; 2015 Dec; 11(6):909-18. PubMed ID: 26210995
[TBL] [Abstract][Full Text] [Related]
31. Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine.
Dodge ME; Moon J; Tuladhar R; Lu J; Jacob LS; Zhang LS; Shi H; Wang X; Moro E; Mongera A; Argenton F; Karner CM; Carroll TJ; Chen C; Amatruda JF; Lum L
J Biol Chem; 2012 Jun; 287(27):23246-54. PubMed ID: 22593577
[TBL] [Abstract][Full Text] [Related]
32. [Novel signal transduction pathways: the molecular basis for targeted cancer therapies in Hedgehog/Notch/Wnt pathway].
Shimizu T; Nakagawa K
Nihon Rinsho; 2015 Aug; 73(8):1342-8. PubMed ID: 26281688
[TBL] [Abstract][Full Text] [Related]
33. Stem cell signaling as a target for novel drug discovery: recent progress in the WNT and Hedgehog pathways.
An SM; Ding QP; Li LS
Acta Pharmacol Sin; 2013 Jun; 34(6):777-83. PubMed ID: 23708555
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of WO2014207069 A1: Multitarget Hedgehog pathway inhibitors and uses thereof.
Manetti F; Petricci E
Expert Opin Ther Pat; 2016; 26(4):529-35. PubMed ID: 26666870
[TBL] [Abstract][Full Text] [Related]
35. Targeting GLI factors to inhibit the Hedgehog pathway.
Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L
Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120
[TBL] [Abstract][Full Text] [Related]
36. Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis.
Beyer C; Dees C; Distler JH
Arch Dermatol Res; 2013 Jan; 305(1):1-8. PubMed ID: 23208311
[TBL] [Abstract][Full Text] [Related]
37. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
[TBL] [Abstract][Full Text] [Related]
38. Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors.
Ho SY; Alam J; Jeyaraj DA; Wang W; Lin GR; Ang SH; Tan ESW; Lee MA; Ke Z; Madan B; Virshup DM; Ding LJ; Manoharan V; Chew YS; Low CB; Pendharkar V; Sangthongpitag K; Hill J; Keller TH; Poulsen A
J Med Chem; 2017 Aug; 60(15):6678-6692. PubMed ID: 28671458
[TBL] [Abstract][Full Text] [Related]
39. Sonic hedgehog, Wnt, and brain-derived neurotrophic factor cell signaling pathway crosstalk: potential therapy for depression.
Tayyab M; Shahi MH; Farheen S; Mariyath MPM; Khanam N; Castresana JS; Hossain MM
J Neurosci Res; 2018 Jan; 96(1):53-62. PubMed ID: 28631844
[TBL] [Abstract][Full Text] [Related]
40. Structure, mechanism, and inhibition of Hedgehog acyltransferase.
Coupland CE; Andrei SA; Ansell TB; Carrique L; Kumar P; Sefer L; Schwab RA; Byrne EFX; Pardon E; Steyaert J; Magee AI; Lanyon-Hogg T; Sansom MSP; Tate EW; Siebold C
Mol Cell; 2021 Dec; 81(24):5025-5038.e10. PubMed ID: 34890564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]